Medicines

For help on how to get the results you want, see our search tips.

Search results

3626 results

Sort by

List item

Ibutilide: List of nationally authorised medicinal products - PSUSA/00001713/201712 (PDF/80.23 KB)

authorised medicinal products - PSUSA/00001713/201712 … authorised medicinal products - PSUSA/00001713/201712 EMA/PRAC/607905/2018 10/09/2018 … ibutilide Procedure no.: PSUSA/00001713/201712 List of nationally …

Last updated: 10/09/2018
Active substance: ibutilide
Procedure number: PSUSA/00001713/201712
Regulatory outcome: Maintenance
List item

Felodipine: List of nationally authorised medicinal products - PSUSA/00001356/201712 (PDF/179.53 KB)

authorised medicinal products - PSUSA/00001356/201712 … authorised medicinal products - PSUSA/00001356/201712 EMA/609153/2018 11/09/2018 … felodipine Procedure no.: PSUSA/00001356/201712 List of nationally …

Last updated: 11/09/2018
Active substance: felodipine
Procedure number: PSUSA/00001356/201712
Regulatory outcome: Maintenance
List item

Betahistine: List of nationally authorised medicinal products - PSUSA/00000389/201712 (PDF/217.94 KB)

authorised medicinal products - PSUSA/00000389/201712 … authorised medicinal products - PSUSA/00000389/201712 EMA/608492/2018 10/09/2018 … betahistine Procedure no.: PSUSA/00000389/201712 List of nationally …

Last updated: 10/09/2018
Active substance: betahistine
Procedure number: PSUSA/00000389/201712
Regulatory outcome: Maintenance
List item

Furosemide: List of nationally authorised medicinal products - PSUSA/00001491/201801 (PDF/184.36 KB)

authorised medicinal products - PSUSA/00001491/201801 … authorised medicinal products - PSUSA/00001491/201801 EMA/608623/2018 10/09/2018 … furosemide Procedure no.: PSUSA/00001491/201801 List of nationally …

Last updated: 10/09/2018
Active substance: Furosemide
Procedure number: PSUSA/00001491/201801
Regulatory outcome: Maintenance
List item

Azelastine: List of nationally authorised medicinal products - PSUSA/00000277/201712 (PDF/220.2 KB)

authorised medicinal products - PSUSA/00000277/201712 … authorised medicinal products - PSUSA/00000277/201712 EMA/612350/2018 10/09/2018 … azelastine Procedure no.: PSUSA/00000277/201712 List of nationally …

Last updated: 10/09/2018
Active substance: azelastine
Procedure number: PSUSA/00000277/201712
Regulatory outcome: Maintenance
List item

Propofol: List of nationally authorised medicinal products - PSUSA/00002555/201711 (PDF/516.62 KB)

authorised medicinal products - PSUSA/00002555/201711 … authorised medicinal products - PSUSA/00002555/201711 EMA/475638/2018 13/09/2018 … propofol Procedure No.: PSUSA/00002555/201711 List of nationally …

Last updated: 13/09/2018
Active substance: propofol
Procedure number: PSUSA/00002555/201711
Regulatory outcome: Variation
List item

Paroxetine: List of nationally authorised medicinal products - PSUSA/00002319/201712 (PDF/348.11 KB)

authorised medicinal products - PSUSA/00002319/201712 … authorised medicinal products - PSUSA/00002319/201712 EMA/612747/2018 11/09/2018 … paroxetine Procedure no.: PSUSA/00002319/201712 …

Last updated: 11/09/2018
Active substance: paroxetine
Procedure number: PSUSA/00002319/201712
Regulatory outcome: Variation
List item

Mizolastine: List of nationally authorised medicinal products - PSUSA/00002078/201711 (PDF/217.66 KB)

authorised medicinal products - PSUSA/00002078/201711 … authorised medicinal products - PSUSA/00002078/201711 EMA/595427/2018 05/09/2018 … mizolastine Procedure no.: PSUSA/00002078/201711 List of nationally …

Last updated: 05/09/2018
Active substance: mizolastine
Procedure number: PSUSA/00002078/201711
Regulatory outcome: Variation
List item

Hydroxycarbamide: List of nationally authorised medicinal products - PSUSA/00009182/201712 (PDF/94.52 KB)

authorised medicinal products - PSUSA/00009182/201712 … authorised medicinal products - PSUSA/00009182/201712 EMA/584534/2018 31/08/2018 … product) Procedure no.: PSUSA/00009182/201712 List of nationally …

Last updated: 31/08/2018
Active substance: hydroxycarbamide
Procedure number: PSUSA/00009182/201712
Regulatory outcome: Variation
List item

Tapentadol : List of nationally authorised medicinal products - PSUSA/00002849/201711 (PDF/1.4 MB)

authorised medicinal products - PSUSA/00002849/201711 … authorised medicinal products - PSUSA/00002849/201711 EMA/607287/2018 07/09/2018 … tapentadol Procedure no.: PSUSA/00002849/201711 List of nationally …

Last updated: 07/09/2018
Active substance: tapentadol
Procedure number: PSUSA/00002849/201711
Regulatory outcome: Variation
List item

Rosuvastatin: List of nationally authorised medicinal products - PSUSA/00002664/201711 (PDF/710.43 KB)

authorised medicinal products - PSUSA/00002664/201711 … authorised medicinal products - PSUSA/00002664/201711 EMA/270645/2015 31/08/2018 … rosuvastatin Procedure no.: PSUSA/00002664/201711 List of nationally …

Last updated: 31/08/2018
Active substance: Rosuvastatin
Procedure number: PSUSA/00002664/201711
Regulatory outcome: Variation
List item

Epinastine: List of nationally authorised medicinal products - PSUSA/00001231/201710 (PDF/130.86 KB)

authorised medicinal products - PSUSA/00001231/201710 … authorised medicinal products - PSUSA/00001231/201710 EMA/553008/2018 14/08/2018 … epinastine PSUSA/1231/201710 30 Churchill Place …

Last updated: 14/08/2018
Active substance: epinastine
Procedure number: PSUSA/00001231/201710
Regulatory outcome: Variation
List item

Glatiramer: List of nationally authorised medicinal products - PSUSA/00001529/201711 (PDF/277.02 KB)

authorised medicinal products - PSUSA/00001529/201711 … authorised medicinal products - PSUSA/00001529/201711 EMA/537197/2018 14/08/2018 … glatiramer PSUSA/00001529/201711 30 Churchill Place …

Last updated: 14/08/2018
Active substance: glatiramer
Procedure number: PSUSA/00001529/201711
Regulatory outcome: Maintenance
List item

Alfuzosin: List of nationally authorised medicinal products - PSUSA/00000084/201711 (PDF/300.84 KB)

authorised medicinal products - PSUSA/00000084/201711 … authorised medicinal products - PSUSA/00000084/201711 EMA/537159/2018 14/08/2018 … alfuzosin PSUSA/00000084/201711 30 Churchill Place …

Last updated: 14/08/2018
Active substance: alfuzosin
Procedure number: PSUSA/00000084/201711
Regulatory outcome: Maintenance
List item

Deoxycholic acid: List of nationally authorised products - PSUSA/00010525/201710 (PDF/134.12 KB)

nationally authorised products - PSUSA/00010525/201710 … nationally authorised products - PSUSA/00010525/201710 EMA/PRAC/380270/2018 14/08/2018 … deoxycholic acid Procedure No.: PSUSA/00010525/201710 EMA/PRAC/384956/2018 …

Last updated: 14/08/2018
Active substance: Deoxycholic acid
Procedure number: PSUSA/00010525/201710
Regulatory outcome: Variation
List item

Prulifloxacin: List of nationally authorised medicinal products - PSUSA/00002569/201710 (PDF/101.7 KB)

authorised medicinal products - PSUSA/00002569/201710 … authorised medicinal products - PSUSA/00002569/201710 EMA/542253/2018 09/08/2018 … authorised medicinal products - PSUSA/00002569/201710 30 Churchill Place …

Last updated: 09/08/2018
Active substance: prulifloxacin
Procedure number: PSUSA/00002569/201710
Regulatory outcome: Variation
List item

Abciximab: List of nationally authorised medicinal products - PSUSA/00000014/201711 (PDF/88.3 KB)

authorised medicinal products - PSUSA/00000014/201711 … authorised medicinal products - PSUSA/00000014/201711 EMA/495549/2018 19/07/2018 … authorised medicinal products – PSUSA/00000014/201711 30 Churchill Place …

Last updated: 19/07/2018
Active substance: abciximab
Procedure number: PSUSA/00000014/201711
Regulatory outcome: Maintenance
List item

Desmopressin: List of nationally authorised medicinal products - PSUSA/00000964/201712 (PDF/373.21 KB)

authorised medicinal products - PSUSA/00000964/201712 … authorised medicinal products - PSUSA/00000964/201712 EMA/PRAC/628699/2018 14/09/2018 …

Last updated: 14/09/2018
Active substance: desmopressin
Procedure number: PSUSA/00000964/201712
Regulatory outcome: Maintenance
List item

Bambuterol: List of nationally authorised medicinal products - PSUSA/00000295/201712 (PDF/72.79 KB)

authorised medicinal products - PSUSA/00000295/201712 … authorised medicinal products - PSUSA/00000295/201712 EMA/488816/2018 18/07/2018 … authorised medicinal products - PSUSA/00000295/201712 30 Churchill Place …

Last updated: 18/07/2018
Active substance: bambuterol
Procedure number: PSUSA/00000295/201712
Regulatory outcome: Maintenance
List item

Clevidipine: List of nationally authorised medicinal products - PSUSA/00010288/201711 (PDF/74.97 KB)

authorised medicinal products - PSUSA/00010288/201711 … authorised medicinal products - PSUSA/00010288/201711 EMA/477218/2018 18/07/2018 … authorised medicinal products; PSUSA/00010288/20171 30 Churchill Place …

Last updated: 18/07/2018
Active substance: clevidipine
Procedure number: PSUSA/00010288/201711
Regulatory outcome: Maintenance
List item

Rupatadine: List of nationally authorised medicinal products - PSUSA/00002673/201712 (PDF/162.42 KB)

authorised medicinal products - PSUSA/00002673/201712 … authorised medicinal products - PSUSA/00002673/201712 EMA/486464/2018 18/07/2018 … authorised medicinal products - PSUSA-00002673-201712 30 Churchill Place …

Last updated: 18/07/2018
Active substance: rupatadine
Procedure number: PSUSA/00002673/201712
Regulatory outcome: Maintenance
List item

Cetirizine: List of nationally authorised medicinal products - PSUSA/00000628/201711 (PDF/254.51 KB)

authorised medicinal products - PSUSA/00000628/201711 … authorised medicinal products - PSUSA/00000628/201711 EMA/490585/2018 18/07/2018 … authorised medicinal products - PSUSA/00000628/201711 30 Churchill Place …

Last updated: 18/07/2018
Active substance: cetirizine
Procedure number: PSUSA/00000628/201711
Regulatory outcome: Maintenance
List item

Bromperidol: List of nationally authorised medicinal products - PSUSA/00000439/201711 (PDF/72.7 KB)

authorised medicinal products - PSUSA/00000439/201711 … authorised medicinal products - PSUSA/00000439/201711 EMA/475623/2018 17/07/2018 … authorised medicinal products - PSUSA/00000439/201711 30 Churchill Place …

Last updated: 17/07/2018
Active substance: bromperidol
Procedure number: PSUSA/00000439/201711
Regulatory outcome: Maintenance
List item

Diacerein: List of nationally authorised medicinal products - PSUSA/00001026/201712 (PDF/96.71 KB)

authorised medicinal products - PSUSA/00001026/201712 … authorised medicinal products - PSUSA/00001026/201712 EMA/483125/2018 17/07/2018 … diacerein PSUSA-00001026-201712 - maintenance 30 Churchill …

Last updated: 17/07/2018
Active substance: Diacerein
Procedure number: PSUSA/00001026/201712
Regulatory outcome: Maintenance
List item

Terbinafine: List of nationally authorised medicinal products - PSUSA/00002896/201709 (PDF/247.53 KB)

authorised medicinal products - PSUSA/00002896/201709 … authorised medicinal products - PSUSA/00002896/201709 … terbinafine Procedure no.: PSUSA/00002896/201709 List of nationally …

Last updated: 18/05/2018
Active substance: terbinafine
Procedure number: PSUSA/00002896/201709
Regulatory outcome: Maintenance

3626 results

Ibutilide: List of nationally authorised medicinal products - PSUSA/00001713/201712 (PDF/80.23 KB)

Felodipine: List of nationally authorised medicinal products - PSUSA/00001356/201712 (PDF/179.53 KB)

Betahistine: List of nationally authorised medicinal products - PSUSA/00000389/201712 (PDF/217.94 KB)

Furosemide: List of nationally authorised medicinal products - PSUSA/00001491/201801 (PDF/184.36 KB)

Azelastine: List of nationally authorised medicinal products - PSUSA/00000277/201712 (PDF/220.2 KB)

Propofol: List of nationally authorised medicinal products - PSUSA/00002555/201711 (PDF/516.62 KB)

Paroxetine: List of nationally authorised medicinal products - PSUSA/00002319/201712 (PDF/348.11 KB)

Mizolastine: List of nationally authorised medicinal products - PSUSA/00002078/201711 (PDF/217.66 KB)

Hydroxycarbamide: List of nationally authorised medicinal products - PSUSA/00009182/201712 (PDF/94.52 KB)

Tapentadol : List of nationally authorised medicinal products - PSUSA/00002849/201711 (PDF/1.4 MB)

Rosuvastatin: List of nationally authorised medicinal products - PSUSA/00002664/201711 (PDF/710.43 KB)

Epinastine: List of nationally authorised medicinal products - PSUSA/00001231/201710 (PDF/130.86 KB)

Glatiramer: List of nationally authorised medicinal products - PSUSA/00001529/201711 (PDF/277.02 KB)

Alfuzosin: List of nationally authorised medicinal products - PSUSA/00000084/201711 (PDF/300.84 KB)

Deoxycholic acid: List of nationally authorised products - PSUSA/00010525/201710 (PDF/134.12 KB)

Prulifloxacin: List of nationally authorised medicinal products - PSUSA/00002569/201710 (PDF/101.7 KB)

Abciximab: List of nationally authorised medicinal products - PSUSA/00000014/201711 (PDF/88.3 KB)

Desmopressin: List of nationally authorised medicinal products - PSUSA/00000964/201712 (PDF/373.21 KB)

Bambuterol: List of nationally authorised medicinal products - PSUSA/00000295/201712 (PDF/72.79 KB)

Clevidipine: List of nationally authorised medicinal products - PSUSA/00010288/201711 (PDF/74.97 KB)

Rupatadine: List of nationally authorised medicinal products - PSUSA/00002673/201712 (PDF/162.42 KB)

Cetirizine: List of nationally authorised medicinal products - PSUSA/00000628/201711 (PDF/254.51 KB)

Bromperidol: List of nationally authorised medicinal products - PSUSA/00000439/201711 (PDF/72.7 KB)

Diacerein: List of nationally authorised medicinal products - PSUSA/00001026/201712 (PDF/96.71 KB)

Terbinafine: List of nationally authorised medicinal products - PSUSA/00002896/201709 (PDF/247.53 KB)